SELLAS Life Sciences Group, Inc. (SLS)
3.30
-0.05
(-1.49%)
USD |
NASDAQ |
Dec 30, 16:00
3.34
+0.04
(+1.21%)
After-Hours: 20:00
SELLAS Life Sciences Group Market Cap: 470.06M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GT Biopharma, Inc. | 8.674M |
| Geron Corp. | 852.20M |
| ADMA Biologics, Inc. | 4.365B |
| Lyell Immunopharma, Inc. | 467.34M |
| NovaBay Pharmaceuticals, Inc. | 772.45M |
Market Cap Related Metrics
| Price to Book Value | 10.30 |
| Price | 3.30 |
| Earnings Yield | -8.69% |